Back to search

Article

CAR-T-drug conjugate against solid tumor

2026-01-02

Abstract excerpt

Chimeric antigen receptor (CAR)-T cell therapy has been clinically successful in hematologic cancers but faces challenges in solid tumors, primarily due to limited tumor infiltration, immunosuppressive tumor microenvironments (TME), and antigen heterogeneity. While combining CAR-T cell therapy with chemotherapy can enhance antitumor activity, this often leads to substantial systemic toxicity. In this study, we int...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
85171c9b-7e10-50d3-9b4f-406c81098cfb
DOI
10.64898/2026.01.02.696502
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAR-T-drug conjugate against solid tumorDOI 10.64898/2026.01.02.696502
Select a neighboring publication to make it the new centre.